Circ_0008717 aggravated the progression of RCC by activating FBXO17 through targeting miR-217, which provided a novel mechanism for circ_0008717 to participate in RCC progression.
Circ_0008717 promotes renal cell carcinoma progression by upregulating FBXO17 via targeting miR-217.